Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: A retrospective analysis

BACKGROUND: Amyloid-related imaging abnormalities (ARIA) have been reported in Alzheimer’s disease (AD) patients treated with bapineuzumab, a humanized monoclonal antibody to amyloid-β. ARIA includes MRI signal abnormalities suggestive of vasogenic edema and sulcal effusions (ARIA-E) and hemosiderin...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sperling, Reisa, Salloway, Stephen, Brooks, David J., Tampieri, Donatella, Barakos, Jerome, Fox, Nick C., Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Lieberburg, Ivan, Arrighi, H. Michael, Morris, Kristen A., Lu, Yuan, Liu, Enchi, Gregg, Keith M., Brashear, Robert H., Kinney, Gene G., Black, Ronald, Grundman, Michael
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063417/
https://ncbi.nlm.nih.gov/pubmed/22305802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(12)70015-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы